News
-
-
-
PRESS RELEASE
Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
Sanofi's Nuvaxovid COVID-19 vaccine demonstrated better tolerability than mNEXSPIKE in a head-to-head study presented at ESCMID Global Congress. Results indicate lower side effects and improved patient experience -
-
PRESS RELEASE
Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Formation Metals Inc. announces response to OTC Markets' request on recent promotional activity. No false/misleading statements found in marketing materials. CEO purchased shares. Company engages third-party marketing firms for services -
-
-
-
-